Brain researchers would dearly love to reliably identify changes in brain structure and metabolism associated with early Alzheimer’s disease -- before symptoms emerge.Such information would buy precious time and perhaps permit potential therapies to delay or even prevent the memory-robbing disease. Now, a new study by NYU School of Medicine researchers brings this goal one step closer to being realized.
